Response to Polygenic Risk: Results of the MyGeneRank Mobile Application-Based Coronary Artery Disease Study
Evan D. Muse, Shang‐Fu Chen, Shuchen Liu, Brianna Fernandez, Brian Schrader, Bhuvan Molparia, André Nicolás León, Raymond Lee, Neha Pubbi, Nolan Mejia, Christina Ren, Ahmed El-kalliny, Ernesto Prado Montes de, Hector E. Tamez, Arjun Ghoshal, , Ali Torkamani
This study evaluates the impact of coronary artery disease polygenic risk scores on lipid-lowering therapy initiation via a mobile application, finding higher therapy rates among high-risk individuals.
npj Digital Medicine · Mar 11, 2022Peer-reviewedGenetic & Genomic Medicine